1. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children. (March 2019) Authors: Pearson, Andrew D.J.; Scobie, Nicole; Norga, Koenraad; Ligas, Franca; Chiodin, Davy; Burke, Amos; Minard-Colin, Veronique; Adamson, Peter; Marshall, Lynley V.; Balakumaran, Arun; Benettaib, Bouchra; Bhargava, Pankaj; Bollard, Catherine M.; Bolotin, Ellen; Bomken, Simon; Buechner, Jochen; Burkhard... Journal: European journal of cancer Issue: Volume 110(2019) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Issue 1 (January 2022) Authors: Jacobson, Caron A; Chavez, Julio C; Sehgal, Alison R; William, Basem M; Munoz, Javier; Salles, Gilles; Munshi, Pashna N; Casulo, Carla; Maloney, David G; de Vos, Sven; Reshef, Ran; Leslie, Lori A; Yakoub-Agha, Ibrahim; Oluwole, Olalekan O; Fung, Henry Chi Hang; Rosenblatt, Joseph; Rossi, John M; ... Journal: Lancet oncology Issue: Volume 23:Issue 1(2022) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Issue 10299 (7th August 2021) Authors: Shah, Bijal D; Ghobadi, Armin; Oluwole, Olalekan O; Logan, Aaron C; Boissel, Nicolas; Cassaday, Ryan D; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; Tzachanis, Dimitrios; O'Dwyer, Kristen M; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Park, Jae H; Subklewe, Marion; Abedi, Me... Journal: Lancet Issue: Volume 398:Issue 10299(2021) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia. Issue 8 (3rd August 2017) Authors: Vey, Norbert; Prebet, Thomas; Thalamas, Claire; Charbonnier, Aude; Rey, Jerome; Kloos, Ioana; Liu, Emily; Luan, Ying; Vezan, Remus; Graef, Thorsten; Recher, Christian Journal: Leukemia & lymphoma Issue: Volume 58:Issue 8(2017) Page Start: 1880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗